This inventor holds 1 USPTO granted patent. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College, The Broad Institute, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,268 
1 out of 3,078 
1 out of 488 
Years Active: 2024
Title: Bruce Kuan-Yee Hua: Innovator in Cancer Treatment
Introduction
Bruce Kuan-Yee Hua is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on addressing proliferative diseases, particularly cancer.
Latest Patents
Bruce Kuan-Yee Hua holds a patent for "Cyclopentaimidazolones for the treatment of cancer." This patent includes compounds that are useful for treating various proliferative diseases, including pancreatic cancer. The compounds, along with their pharmaceutically acceptable salts, can be formulated into pharmaceutical compositions and utilized in methods for treatment and prophylaxis of these diseases.
Career Highlights
Throughout his career, Bruce has worked with prestigious organizations such as the Broad Institute, Inc. and Dana-Farber Cancer Institute Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Some of his notable coworkers include Srivatsan Raghavan and Shubhroz Gill. Their collaborative efforts have contributed to advancements in cancer treatment methodologies.
Conclusion
Bruce Kuan-Yee Hua's innovative work in developing compounds for cancer treatment highlights his commitment to improving healthcare outcomes. His contributions are vital in the ongoing fight against cancer, particularly pancreatic cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile